AGM
LYRA

Alpine Global Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Alpine Global Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-929
Closed -$12.8K – 318
2024
Q2 		$12.8K Buy
+929
New +$105K ﹤0.01% 454

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpine Global Management's LYRA Position: Q3 2024 in Review

Alpine Global Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2024, closing a stake of 929 shares — an estimated $12.8K sold.

Alpine Global Management first reported a position in LYRA in Q2 2024 and held it in 1 quarter. The position peaked at $12.8K in Q2 2024. 62 funds tracked by Wall St. Rank hold LYRA as of Q3 2024.

  • Alpine Global Management reported no remaining LYRA THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 929 LYRA THERAPEUTICS INC shares in Q3 2024, an estimated $12.8K.
  • Alpine Global Management first reported a position in LYRA THERAPEUTICS INC in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's LYRA THERAPEUTICS INC position peaked at $12.8K in Q2 2024.
  • 62 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.